- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: anti-PD-L1 monoclonal antibody
Total 103464 results
-
Merck Sharp & Dohme LLCTerminatedNeoplasms | Head and Neck Neoplasms | Colorectal NeoplasmsAustralia, Hong Kong
-
Instituto Portugues de Oncologia, Francisco Gentil...AstraZenecaRecruiting
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI); Incyte CorporationRecruitingPancreatic Cancer Metastatic | Pancreatic Cancer Non-resectableUnited States
-
BioMérieuxCompletedMalaria | Dengue | ChikungunyaBurkina Faso, Côte D'Ivoire
-
Hospital of Stomatology, Wuhan UniversityRecruitingClinical IVb Stage Oral Squamous Cell Carcinomas PatientsChina
-
M.D. Anderson Cancer CenterRecruitingStage III Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Stage IIIC Lung Cancer AJCC v8 | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage III Lung Non-Small Cell Cancer AJCC v7United States
-
Istituto Oncologico Veneto IRCCSUniversity of Padova; Dipartimento di scienze chirurgiche, Oncologiche e GastroenterologicheActive, not recruitingTriple Negative Breast NeoplasmsItaly, United Kingdom
-
Xiaohua ZhuRecruitingNSCLC Stage IV | PD-L1 Gene AmplificationChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingUterine Cervical CancerChina
-
Sun Yat-sen UniversityWest China Hospital; Nanfang Hospital, Southern Medical UniversityNot yet recruitingNasopharyngeal Carcinoma | Nasopharyngeal CancerChina
-
Tongji HospitalZhejiang Cancer Hospital; Xiangya Hospital of Central South University; Beijing... and other collaboratorsNot yet recruitingCervical Cancer | Locally Advanced Cervical Cancer | PD-L1 Negative | Neoadjuvant ChemoimmunotherapyChina
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); AstraZeneca; Juno Therapeutics, Inc.; MedImmune...TerminatedRecurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedUnited States
-
Memorial Sloan Kettering Cancer CenterENABLE MEDICINEActive, not recruitingSarcoma | Leiomyosarcoma | High Grade Sarcoma | Undifferentiated Pleomorphic Sarcoma | Advanced Sarcoma | Myxofibrosarcoma | Dedifferentiated LiposarcomaUnited States
-
CureVacSyneos Health; Cromos Pharma LLCActive, not recruitingCarcinoma, Adenoid Cystic | Melanoma (Skin) | Squamous Cell Carcinoma of the Skin | Carcinoma, Squamous Cell of Head and NeckSpain, France, Austria, Germany, Russian Federation
-
Fondazione Ricerca TraslazionaleUnknownCarcinoma, Non-Small-Cell Lung
-
Jounce Therapeutics, Inc.Completed
-
Agenus Inc.Terminated
-
Merck Sharp & Dohme LLCTerminated
-
Genentech, Inc.CompletedNon-Small Cell Lung CancerUnited States
-
AstraZenecaCompletedRecurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHNUnited States, France, Italy, Spain, Belgium, Czechia, Romania, Taiwan, Korea, Republic of, Brazil, Hungary, Japan, Russian Federation, Australia, Germany, Israel, Serbia, Bulgaria, Ukraine, Argentina, Poland, Chile, Croatia, Georgia
-
Lee's Pharmaceutical LimitedCompletedExtensive-stage Small-cell Lung CancerChina
-
Merck Sharp & Dohme LLCCompleted
-
AstraZenecaActive, not recruitingNon Small Cell Lung Carcinoma NSCLCPoland, Taiwan, Thailand, Vietnam, United States, Korea, Republic of, Hungary, Russian Federation, Turkey, China, Australia, Netherlands
-
Olivia Newton-John Cancer Research InstituteAustin Health; Merck Healthcare KGaATerminated
-
Istari Oncology, Inc.Active, not recruiting
-
Cancer Institute and Hospital, Chinese Academy...UnknownDiffuse Large B-Cell Lymphoma | Sintilimab | TP53 Mutation
-
PharmAbcineMerck Sharp & Dohme LLC; Novotech (Australia) Pty LimitedNot yet recruitingAdvanced or Metastatic Solid TumorsAustralia
-
Biotheus Inc.Recruiting
-
Peking Union Medical College HospitalCompletedEsophageal Squamous Cell CarcinomaChina
-
First Affiliated Hospital of Zhejiang UniversityHoffmann-La Roche; Geneplus-Beijing Co. Ltd.UnknownNon-Small Cell Lung CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedAdvanced Solid TumorsChina
-
United Nations Office on Drugs and Crime (UNODC)Polytechnique University of the Philippines; Anti-Drug Abuse Councils, LGUs...Enrolling by invitationFamily Relationship | Parenting SkillsPhilippines
-
Lee's Pharmaceutical LimitedEnrolling by invitationBiliary Tract CancerChina
-
AstraZenecaRecruitingCarcinoma, Non-Small-Cell Lung | Gastric Cancer | Gastroesophageal Junction CancerUnited States, Canada, Spain, China, Japan, France, Turkey, Netherlands, Moldova, Republic of, Georgia
-
Gustave Roussy, Cancer Campus, Grand ParisActive, not recruitingAtezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours (SABR-PDL1)Patients With Metastatic Tumours (Colorectal Cancer, Non-small Lung Cancer, Renal Cell Carcinoma or Sarcoma )France
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
AkesoCompletedHCC | Lung Cancer | Solid TumorChina
-
Greg Durm, MDMerck Sharp & Dohme LLC; Big Ten Cancer Research ConsortiumCompleted
-
AkesoAkeso Pharmaceuticals, Inc.CompletedMelanoma | Advanced Solid TumorsChina
-
The First Hospital of Jilin UniversityNot yet recruitingLocally Advanced Rectal Cancer | Anti-PD-1 | Total Neoadjuvant TreatmentChina
-
Beijing Tongren HospitalNot yet recruitingExtranodal NK/T-cell Lymphoma, Nasal Type
-
Cancer Institute and Hospital, Chinese Academy...RecruitingAdvanced Lung CarcinomaChina
-
University of LeipzigRecruitingHepatocellular CarcinomaGermany
-
Waterstone Hanxbio Pty LtdCompletedAdvanced Solid TumorAustralia
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingMelanoma | Metastatic Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Recurrent Metastatic MelanomaUnited States
-
OncoC4, Inc.BioNTech SERecruitingONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors (PRESERVE-003)Non Small Cell Lung CancerUnited States, Belgium, Canada, France, Germany, Italy, Spain, China, Korea, Republic of, Netherlands, Turkey, United Kingdom, Australia
-
Shanghai Public Health Clinical CenterRecruiting
-
Agenus Inc.CompletedAdvanced Solid Cancers | Advanced Solid Cancers Refractory to PD-1United States
-
NanoMab Technology (UK) LimitedKing's College London; Guy's and St Thomas' NHS Foundation TrustRecruiting